For the year ending 2025-12-31, GH has $2,013,659K in assets. $2,112,966K in debts. $378,203K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 378,203 | 525,540 | 1,133,537 | 141,647 |
| Short-term marketable debt securities | 823,395 | 314,438 | 35,097 | 869,584 |
| Accounts receivable, net | 137,849 | 110,253 | 88,783 | 97,256 |
| Inventory, net | 85,876 | 71,083 | 61,948 | 51,598 |
| Prepaid expenses and other current assets, net | 40,723 | 33,800 | 27,741 | 31,509 |
| Total current assets | 1,466,046 | 1,055,114 | 1,347,106 | 1,191,594 |
| Restricted cash | 111,214 | 104,215 | - | - |
| Property and equipment, net | 145,915 | 136,813 | 145,096 | 167,920 |
| Right-of-use assets, net | 158,849 | 142,265 | 157,616 | 174,001 |
| Long-term marketable debt securities | - | - | - | 0 |
| Intangible assets, net | 25,921 | 6,760 | 8,979 | 11,727 |
| Goodwill | 77,257 | 3,290 | 3,290 | 3,290 |
| Other assets, net | 28,457 | 37,152 | 124,334 | 61,453 |
| Total assets | 2,013,659 | 1,485,609 | 1,786,421 | 1,609,985 |
| Accounts payable | 54,442 | 38,551 | - | - |
| Accrued compensation | 119,646 | 83,219 | - | - |
| Accrued expenses | 77,889 | 68,345 | - | - |
| Deferred revenue | 50,753 | 35,468 | 17,965 | - |
| Accounts payable and accrued liabilities | - | - | 187,952 | 175,817 |
| Deferred revenue | - | - | - | 17,403 |
| Noncontrolling interest liability | - | - | - | 0 |
| Total current liabilities | 302,730 | 225,583 | 205,917 | 193,220 |
| Convertible senior notes, net | 1,504,000 | 1,142,547 | 1,139,966 | 1,137,391 |
| Long-term operating lease liabilities | 178,463 | 164,292 | 185,848 | 210,015 |
| Other long-term liabilities | 127,773 | 92,834 | 96,006 | 9,179 |
| Total liabilities | 2,112,966 | 1,625,256 | 1,627,737 | 1,549,805 |
| Common stock, par value of 0.00001 per share 350,000,000 shares authorized as of december31, 2025 and 2024 130,635,301 and 123,994,006 shares issued and outstanding as of december31, 2025 and 2024, respectively | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 2,900,056 | 2,443,788 | 2,304,220 | 1,742,114 |
| Accumulated other comprehensive loss | -4,852 | -5,201 | -3,675 | -19,522 |
| Accumulated deficit | -2,994,512 | -2,578,235 | -2,141,862 | -1,662,413 |
| Total stockholders deficit | -99,307 | -139,647 | 158,684 | 60,180 |
| Total liabilities and stockholders deficit | 2,013,659 | 1,485,609 | 1,786,421 | 1,609,985 |
Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH)